Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23742877 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
Conditions: Prostatic Neoplasms;   Neoplasm Metastasis
Interventions: Drug: Aflibercept;   Drug: Placebo (for aflibercept);   Drug: Docetaxel;   Drug: Prednisone or Prednisolone

Indicates status has not been verified in more than two years